Should I Buy IOSP? IOSP 2026 Analysis

Should You Buy Innospec Inc (IOSP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

81.410

1 Day change

2.71%

52 Week Range

116.950

Analysis Updated At

2026/01/26

Innospec Inc (IOSP) is not a strong buy for a beginner, long-term investor at this time. The stock's recent financial performance shows significant declines in revenue, net income, and EPS, which raises concerns about its growth potential. While analysts have a positive outlook with a Buy rating and a $93 price target, the lack of recent positive news, weak technical indicators, and no significant trading signals suggest that it is better to wait for clearer signs of recovery or growth before investing.

Technical Analysis

The technical indicators are neutral. The MACD is slightly positive but contracting, RSI is neutral at 55.314, and moving averages are converging. The stock is trading near its pivot point of 80.384, with key resistance at 82.113 and support at 78.655. There are no strong signals indicating a clear upward or downward trend.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Analysts have initiated a Buy rating with a $93 price target, citing the stock as undervalued and highlighting potential upside from new products or M&A opportunities.

Neutral/Negative Catalysts

The company reported a significant decline in financial performance for Q3 2025, with revenue down 0.34% YoY, net income down 61.38% YoY, and EPS down 60.90% YoY. Gross margin also declined by 5.64%. Additionally, there are no recent news updates or significant trading trends to support a bullish sentiment.

Financial Performance

In Q3 2025, Innospec reported revenue of $441.9M, down 0.34% YoY. Net income dropped to $12.9M, a 61.38% YoY decline, and EPS fell to $0.52, down 60.90% YoY. Gross margin decreased to 26.41%, down 5.64% YoY. These metrics indicate a challenging financial period for the company.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Freedom Capital initiated coverage with a Buy rating and a $93 price target, citing the stock as undervalued with potential upside from new products or M&A opportunities. However, the stock's recent underperformance and bottoming earnings are noted as risks.

1 Analyst Rating

Wall Street analysts forecast IOSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IOSP is 93 USD with a low forecast of 93 USD and a high forecast of 93 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 79.260

Low

Averages

High

Current: 79.260

Low

Averages

High

Freedom Capital

initiated

$93

AI Analysis

2025-11-17

Reason

Freedom Capital

Price Target

$93

AI Analysis

2025-11-17

initiated

Reason

Freedom Capital initiated coverage of Innospec with a Buy rating and $93 price target, calling the company an "undervalued" specialty chemicals maker. The firm said it sees potential upside from either new product offerings or opportunistic M&A. Freedom Capital noted that the stock's recent underperformance along with its bottoming earnings "create an attractive risk-reward tradeoff."

Seaport Global

Michael Harrison

Hold

Strong Buy

Upgrades

$155

2025-04-21

Reason

Seaport Global

Michael Harrison

Price Target

$155

2025-04-21

Upgrades

Hold

Strong Buy

Reason

IOSP Should I Buy

IOSP Should I Buy

Should You Buy Innospec Inc (IOSP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch